Supriya Lifesci.

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "680.50",
    "chg": 11.55,
    "chgp": "1.73%",
    "dir": 1,
    "prev_price": "668.95",
    "mcapval": "5,476.85 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE07RO01027",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "1.09 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-market-signals-3827961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SupriyaLifescie_technicaldot_3827961.png",
        "date": "2026-02-09 08:03:15",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "When is the next results date for Supriya Lifescience Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-supriya-lifescience-ltd-3819228",
        "imagepath": "",
        "date": "2026-02-03 23:17:56",
        "description": "The next results date for Supriya Lifescience Ltd is scheduled for February 9, 2026...."
      },
      {
        "title": "Supriya Lifescience Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3818477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SupriyaLifescie_gapup_3818477.png",
        "date": "2026-02-03 11:21:22",
        "description": "Supriya Lifescience Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 12.33% higher than its previous close. This robust start underscores a positive shift in market sentiment within the Pharmaceuticals & Biotechnology sector, as the stock outperformed both its sector peers and the broader Sensex index."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-3814228",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SupriyaLifescie_mojoScore_3814228.png",
        "date": "2026-02-01 10:10:04",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3798311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_mojoScore_3798311.png",
        "date": "2026-01-21 10:10:03",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3789345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_technicaldot_3789345.png",
        "date": "2026-01-12 08:04:06",
        "description": "Supriya Lifescience Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade from a Sell to a Hold rating by MarketsMOJO on 20 Oct 2025. Despite a recent 3.55% decline in share price, the stock’s technical indicators reveal a complex picture of mildly bullish and bearish signals across different timeframes, suggesting cautious optimism among investors."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3788135",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_mojoScore_3788135.png",
        "date": "2026-01-10 10:10:05",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Supriya Lifescience Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-shows-bullish-momentum-amid-technical-upgrades-3786446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SupriyaLifescie_technicaldot_3786446.png",
        "date": "2026-01-09 08:09:12",
        "description": "Supriya Lifescience Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a mix of positive signals from key indicators such as moving averages and Bollinger Bands. Despite some mixed signals from MACD and KST, the stock’s recent performance and technical upgrades suggest growing investor confidence within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-3774968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SupriyaLifescie_mojoScore_3774968.png",
        "date": "2025-12-30 10:10:04",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date perspective on its performance and outlook."
      }
    ],
    "total": 275,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Feb-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that an earnings call will be held on Tuesday February 10 2026 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31 2025. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Exchanges separately. Kindly take the information on record.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "02-Feb-2026",
      "details": "Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Monday February 09 2026 inter alia to Consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025. This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives is closed from January 01 2026 till 48 hours after declaration of Unaudited Financial Results on February 09 2026. Kindly take the above information on your records.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations 2018 for quarter ended December 31 20205 is enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(09 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-09 08:03:15

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend as of early February 2026. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

When is the next results date for Supriya Lifescience Ltd?

2026-02-03 23:17:56

The next results date for Supriya Lifescience Ltd is scheduled for February 9, 2026....

Read full news article

Supriya Lifescience Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 11:21:22

Supriya Lifescience Ltd commenced trading on 3 Feb 2026 with a significant gap up, opening 12.33% higher than its previous close. This robust start underscores a positive shift in market sentiment within the Pharmaceuticals & Biotechnology sector, as the stock outperformed both its sector peers and the broader Sensex index.

Read full news article

Supriya Lifescience Ltd is Rated Hold

2026-02-01 10:10:04

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2026-01-21 10:10:03

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-12 08:04:06

Supriya Lifescience Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflected in a downgrade from a Sell to a Hold rating by MarketsMOJO on 20 Oct 2025. Despite a recent 3.55% decline in share price, the stock’s technical indicators reveal a complex picture of mildly bullish and bearish signals across different timeframes, suggesting cautious optimism among investors.

Read full news article

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2026-01-10 10:10:05

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Supriya Lifescience Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-01-09 08:09:12

Supriya Lifescience Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a mix of positive signals from key indicators such as moving averages and Bollinger Bands. Despite some mixed signals from MACD and KST, the stock’s recent performance and technical upgrades suggest growing investor confidence within the Pharmaceuticals & Biotechnology sector.

Read full news article

Supriya Lifescience Ltd is Rated Hold by MarketsMOJO

2025-12-30 10:10:04

Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

View All News